SASanofi SAN.PA · PAR
79.98 € +5.03% (+3.83 €)
- Market cap
- 91.2B €
- Enterprise value
- 108.4B €
- P/E
- 23.0x
- Forward P/E
- 8.9x
- PEG
- 0.3x
- P/S
- 1.9x
- P/FCF
- 5.5x
- EV/EBITDA
- 13.1x
- ROIC
- 7.4%
- Gross margin
- 72.8%
- Net margin
- 8.1%
- Dividend yield
- 5.41%
- Payout ratio
- 124.7%
- Net debt/EBITDA
- 2.1x
- Beta
- 0.28
- Free float
- 90.0%
About the company
Sanofi (SNY) is a global pharmaceutical company headquartered in France. It focuses on research, development, manufacturing, and distribution of medicinal products in various therapeutic areas. Sanofi has a broad portfolio of pharmaceutical products, including medications for cardiovascular diseases, respiratory diseases, diabetes, immune system disorders, and more. The company is known for its innovative drugs and vaccines that contribute to the improvement of global healthcare. With a long history, extensive research efforts, and a strong global presence, Sanofi has become a key player in the pharmaceutical market. Sanofi (SNY) shares represent an attractive investment opportunity for investors seeking a stable and promising investment in the healthcare sector.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
74,846
Headquarters
Paris
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 12% this fiscal year.
- What to watch: Revenue grew by only 2.7% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 EUR of revenue, 34 EUR is left as free cash.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 21 years in a row.
- What speaks for it: It bought back its own shares for 5.03B € in the last fiscal year, 5.5% of its market value.
- What to watch: It pays out more in dividends than it earns: 125% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number